Deltex Medical Group PLC (LSE:DEMG) - Share price


Stock Report

Deltex Medical Group PLC DEMG

Last Price
GBX1.65

Day Change
0.00|0.00%

As of 02/06/2020
11:09:03 BST | GBX
Minimum 15 Minutes Delay.

Last Close1.65p
Day Range1.58 - 1.72
Mkt Cap8.66Mil
52-Wk Range0.80 - 2.90
Yield %-
ISINGB0059337583
Volume200,159
P/E-
P/S0.02
P/CF0.14

Share Price

Total Returns 01/06/2020

 Chg (%)  
More ...
Deltex Medical Group PLC-17.50 
FTSE 100 TR GBP8.33
 
Financials
201720182019
More ...
Income Statement
Turnover5.874.964.26
Operating Profit-1.93-1.060.10
Net Profit-2.00-1.26-0.16
Reported EPS-0.70-0.30-0.03
Balance Sheet
Current Assets3.123.183.29
Non Current Assets2.763.183.20
Total Assets5.886.366.50
Current Liabilities3.462.542.39
Total Liabilities---
Total Equity1.302.382.66
Cash Flow
Operating Cash Flow-1.04-1.410.55
Net Change in Cash-0.350.350.34
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
17/12/2019PurchaseProf Sir Duncan Kirkbride Nichol CBE1.12446,4295,000.00
17/12/2019PurchaseMr. Nigel John Keen1.121,821,42920,400.00
17/12/2019PurchaseMr. Julian Cazalet1.12892,85710,000.00
17/12/2019PurchaseMr. Mark Alexander Wippell1.12892,85710,000.00

Company Profile

Deltex Medical Group PLC develops, designs, manufactures and markets medical equipment that deploys low-frequency ultrasound to visualise and measure blood flow in the central circulation. The company's segments are Probes and Other.

Sector

Medical Devices

Index

FTSE AIM All-Share

Next Event 03/06/2020

Annual General Meeting
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-0.90
Op Mrgn0.02
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorProf Sir Duncan Kirkbride Nichol CBE
Non-Executive Director, ChairmanMr. Nigel John Keen
Non-Executive DirectorMr. Julian Cazalet
Non-Executive DirectorMr. Mark Alexander Wippell
Non-Executive DirectorMr. Christopher Michael Jones
Executive Director, Chief Executive OfficerMr. Andrew Jonathan Mears
Executive Director, Finance Director and Company SecretaryMr. David Philip Moorhouse
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.